BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25700705)

  • 1. Trifluridine Induces p53-Dependent Sustained G2 Phase Arrest with Its Massive Misincorporation into DNA and Few DNA Strand Breaks.
    Matsuoka K; Iimori M; Niimi S; Tsukihara H; Watanabe S; Kiyonari S; Kiniwa M; Ando K; Tokunaga E; Saeki H; Oki E; Maehara Y; Kitao H
    Mol Cancer Ther; 2015 Apr; 14(4):1004-13. PubMed ID: 25700705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA.
    Sakamoto K; Yokogawa T; Ueno H; Oguchi K; Kazuno H; Ishida K; Tanaka N; Osada A; Yamada Y; Okabe H; Matsuo K
    Int J Oncol; 2015; 46(6):2327-34. PubMed ID: 25901475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Antiproliferative Activity of Oxypeucedanin via Induction of G
    Park SH; Hong JY; Park HJ; Lee SK
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models.
    Tanaka N; Sakamoto K; Okabe H; Fujioka A; Yamamura K; Nakagawa F; Nagase H; Yokogawa T; Oguchi K; Ishida K; Osada A; Kazuno H; Yamada Y; Matsuo K
    Oncol Rep; 2014 Dec; 32(6):2319-26. PubMed ID: 25230742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
    Chiu SJ; Lee YJ; Hsu TS; Chen WS
    Chem Biol Interact; 2009 Dec; 182(2-3):173-82. PubMed ID: 19735649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antibodies against 5-bromo-2'-deoxyuridine specifically recognize trifluridine incorporated into DNA.
    Kitao H; Morodomi Y; Niimi S; Kiniwa M; Shigeno K; Matsuoka K; Kataoka Y; Iimori M; Tokunaga E; Saeki H; Oki E; Maehara Y
    Sci Rep; 2016 May; 6():25286. PubMed ID: 27137226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
    Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA Replication Stress Induced by Trifluridine Determines Tumor Cell Fate According to p53 Status.
    Kataoka Y; Iimori M; Fujisawa R; Morikawa-Ichinose T; Niimi S; Wakasa T; Saeki H; Oki E; Miura D; Tsurimoto T; Maehara Y; Kitao H
    Mol Cancer Res; 2020 Sep; 18(9):1354-1366. PubMed ID: 32467171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel quinazoline-based analog induces G2/M cell cycle arrest and apoptosis in human A549 lung cancer cells via a ROS-dependent mechanism.
    Shi H; Li Y; Ren X; Zhang Y; Yang Z; Qi C
    Biochem Biophys Res Commun; 2017 Apr; 486(2):314-320. PubMed ID: 28302490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
    Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
    Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAS-102, a novel antitumor agent: a review of the mechanism of action.
    Lenz HJ; Stintzing S; Loupakis F
    Cancer Treat Rev; 2015 Nov; 41(9):777-83. PubMed ID: 26428513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate-Induced p85α⁻PTEN Complex Formation Causes G
    Hung KC; Wang SG; Lin ML; Chen SS
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin.
    McVean M; Weinberg WC; Pelling JC
    Mol Carcinog; 2002 Jan; 33(1):36-43. PubMed ID: 11807956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Middle infrared radiation induces G2/M cell cycle arrest in A549 lung cancer cells.
    Chang HY; Shih MH; Huang HC; Tsai SR; Juan HF; Lee SC
    PLoS One; 2013; 8(1):e54117. PubMed ID: 23335992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
    Vikhanskaya F; Erba E; D'Incalci M; Broggini M
    Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AZD6738 promotes the tumor suppressive effects of trifluridine in colorectal cancer cells.
    Harata S; Suzuki T; Takahashi H; Hirokawa T; Kato A; Watanabe K; Yanagita T; Ushigome H; Shiga K; Ogawa R; Mitsui A; Kimura M; Matsuo Y; Takiguchi S
    Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36734271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference of cell cycle arrests induced by lidamycin in human breast cancer cells.
    Liu X; He H; Feng Y; Zhang M; Ren K; Shao R
    Anticancer Drugs; 2006 Feb; 17(2):173-9. PubMed ID: 16428935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.